Vistin Pharma revenue falls 9% in first half as EBITDA declines

Verifying

verifying reliability

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Vistin Pharma revenue falls 9% in first half as EBITDA declines - CoinPost Terminal